NPI: 1023063187 · SCOTTSDALE, AZ 85254 · Glaucoma Specialist (Ophthalmology) Physician · NPI assigned 05/24/2006
Authorized official BROOKFIELD, ARTHUR controls 20+ related entities in our dataset. Read more
| Authorized Official | BROOKFIELD, ARTHUR (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: BROOKFIELD, ARTHUR
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 51,117 | $2.36M |
| 2019 | 47,992 | $2.52M |
| 2020 | 37,243 | $2.08M |
| 2021 | 46,090 | $2.71M |
| 2022 | 39,081 | $2.40M |
| 2023 | 31,355 | $2.08M |
| 2024 | 26,455 | $1.81M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 44,265 | 40,764 | $3.10M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 26,634 | 25,367 | $2.70M |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 9,601 | 7,555 | $2.42M |
| 00142 | 19,784 | 17,400 | $1.48M | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36,573 | 32,596 | $992K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 16,689 | 14,262 | $818K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19,228 | 17,708 | $677K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 8,640 | 8,186 | $588K |
| 67028 | Intravitreal injection of a pharmacologic agent | 8,690 | 7,695 | $586K |
| 92134 | 18,612 | 16,967 | $384K | |
| J0178 | Injection, aflibercept, 1 mg | 307 | 226 | $334K |
| 92250 | 9,201 | 9,004 | $245K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3,535 | 3,392 | $224K |
| 92133 | 11,193 | 10,273 | $204K | |
| 92083 | 5,958 | 5,382 | $178K | |
| 92136 | 8,381 | 6,158 | $157K | |
| 92015 | Determination of refractive state | 10,168 | 9,991 | $126K |
| J7999 | Compounded drug, not otherwise classified | 2,187 | 1,760 | $111K |
| J9035 | Injection, bevacizumab, 10 mg | 722 | 707 | $93K |
| V2020 | Frames, purchases | 3,306 | 2,826 | $63K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 2,975 | 1,824 | $58K |
| 66821 | 632 | 465 | $58K | |
| 00145 | 266 | 254 | $47K | |
| 92002 | 535 | 525 | $37K | |
| 76519 | 1,557 | 1,288 | $33K | |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 1,250 | 1,152 | $31K |
| V2624 | Polishing/resurfacing of ocular prosthesis | 1,063 | 856 | $27K |
| 92020 | 2,039 | 1,804 | $26K | |
| J2778 | Injection, ranibizumab, 0.1 mg | 40 | 38 | $25K |
| 00140 | 155 | 146 | $16K | |
| 67210 | 47 | 40 | $14K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | 1,258 | 1,015 | $13K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 592 | 590 | $11K |
| 67041 | 13 | 13 | $10K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 387 | 347 | $8K |
| J1095 | Injection, dexamethasone 9 percent, intraocular, 1 microgram | 44 | 39 | $8K |
| 99152 | 394 | 337 | $8K | |
| V2744 | Tint, photochromatic, per lens | 224 | 167 | $6K |
| 76514 | 897 | 774 | $6K | |
| 66982 | 13 | 13 | $5K | |
| 92285 | 444 | 419 | $5K | |
| 15823 | 20 | 14 | $5K | |
| 92081 | 212 | 193 | $3K | |
| 68841 | 358 | 295 | $3K | |
| 66761 | 14 | 12 | $3K | |
| 67228 | 12 | 12 | $3K | |
| 92235 | 18 | 17 | $1K | |
| 65855 | 13 | 12 | $1K | |
| V2104 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, 2.12 to 4.00d cylinder, per lens | 51 | 51 | $419.52 |
| V2025 | Deluxe frame | 60 | 59 | $377.92 |
| V2750 | Anti-reflective coating, per lens | 76 | 70 | $0.00 |